Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.39
(-0.41%)
CNY 14.39
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.52 Billion | 5.44 Billion | 4.06 Billion | 2.64 Billion | 2.01 Billion | 1.86 Billion |
| Cost of Revenue | 3.44 Billion | 3.55 Billion | 2.7 Billion | 1.65 Billion | 1.31 Billion | 1.24 Billion |
| Gross Profit | 2.07 Billion | 1.88 Billion | 1.35 Billion | 992.89 Million | 702.61 Million | 620.51 Million |
| Operating Expenses | 904.15 Million | 773.65 Million | 555.96 Million | 458.24 Million | 393 Million | 367.13 Million |
| Selling, General and Administrative Expenses | 488.42 Million | 153.95 Million | 129.17 Million | 119.83 Million | 117.58 Million | 111.07 Million |
| Research and Development Expenses | 330.82 Million | 287.37 Million | 173.35 Million | 114.22 Million | 94.5 Million | 87.15 Million |
| Other Expenses | - | 332.31 Million | 253.42 Million | 224.18 Million | 180.92 Million | -17.23 Million |
| Cost and Expenses | 4.34 Billion | 4.33 Billion | 3.26 Billion | 2.11 Billion | 1.7 Billion | 1.6 Billion |
| Operating Income | 1.17 Billion | 1.1 Billion | 753.63 Million | 456.14 Million | 285.43 Million | 193.74 Million |
| Interest Expense | 25.2 Million | 22.37 Million | 24.86 Million | 43.54 Million | 9.96 Million | 3.98 Million |
| Income Tax Expense | 149.27 Million | 183.27 Million | 110.58 Million | 70.01 Million | 49.95 Million | 36.67 Million |
| Earnings before Tax | 1.18 Billion | 1.1 Billion | 744.73 Million | 449.9 Million | 286.92 Million | 192.59 Million |
| Net Income | 1.03 Billion | 921.17 Million | 633.9 Million | 380.58 Million | 237.79 Million | 157.14 Million |
| Earnings Per Share Basic | 1.16 | 1.11 | 0.77 | 0.47 | 0.30 | 0.20 |
| Earnings Per Share Diluted | 1.16 | 1.11 | 0.76 | 0.47 | 0.30 | 0.20 |
| Weighted Average Shares Outstanding | 890.73 Million | 829.65 Million | 823.24 Million | 803.3 Million | 803.3 Million | 785.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 890.73 Million | 829.65 Million | 834.08 Million | 803.3 Million | 803.3 Million | 785.73 Million |
| Gross Margin | 0.38 | 0.35 | 0.33 | 0.38 | 0.35 | 0.33 |
| EBIT Margin | 0.29 | 0.29 | 0.28 | 0.28 | 0.24 | 0.22 |
| Profit Margin | 0.19 | 0.17 | 0.16 | 0.14 | 0.12 | 0.08 |
| EBITDA | 1.59 Billion | 1.47 Billion | 1.06 Billion | 744.77 Million | 487.81 Million | 372.33 Million |
| Earnings Before Tax Margin | 0.21 | 0.20 | 0.19 | 0.17 | 0.14 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 1.27 Billion | 1.45 Billion | 929.95 Million | 5.47 Billion | 1.32 Billion |
| Cost of Revenue | 796.46 Million | 843.64 Million | 973.33 Million | 689.3 Million | 3.55 Billion | 772.84 Million |
| Gross Profit | 404.52 Million | 433.48 Million | 482.03 Million | 240.65 Million | 1.92 Billion | 549.11 Million |
| Operating Expenses | 212.29 Million | 196.58 Million | 227.44 Million | 187.05 Million | 836.76 Million | 191.38 Million |
| Selling, General and Administrative Expenses | 312.8 Million | 83.64 Million | 162.46 Million | 87 Million | - | 327.3 Million |
| Research and Development Expenses | 80.12 Million | 86.77 Million | 64.87 Million | 74.51 Million | - | 72.81 Million |
| Other Expenses | -180.63 Million | -26.16 Million | -108.2 Thousand | -25.53 Million | -64.83 Million | -1.19 Million |
| Cost and Expenses | 1 Billion | 1.04 Billion | 1.2 Billion | 876.35 Million | 4.38 Billion | 964.23 Million |
| Operating Income | 192.42 Million | 236.89 Million | 254.59 Million | 53.6 Million | 1.08 Billion | 370.9 Million |
| Interest Expense | 2.07 Million | 6.16 Million | 8.07 Million | 3.62 Million | 21.73 Million | 7.26 Million |
| Income Tax Expense | 34.6 Million | 35.38 Million | 43.86 Million | 25.68 Million | 149.27 Million | 27.16 Million |
| Earnings before Tax | 191.83 Million | 277.81 Million | 282.38 Million | 95.26 Million | 1.18 Billion | 370.28 Million |
| Net Income | 155.88 Million | 238.22 Million | 236.75 Million | 66.48 Million | 1.03 Billion | 345.04 Million |
| Earnings Per Share Basic | 0.17 | 0.27 | 0.26 | 0.07 | - | 0.38 |
| Earnings Per Share Diluted | 0.17 | 0.27 | 0.26 | 0.07 | - | 0.38 |
| Weighted Average Shares Outstanding | 898.1 Million | 898.28 Million | 899.48 Million | 899.48 Million | 890.73 Million | 899.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 898.1 Million | 898.28 Million | 899.48 Million | 899.48 Million | 890.73 Million | 899.49 Million |
| Gross Margin | 0.34 | 0.34 | 0.33 | 0.26 | 0.35 | 0.42 |
| EBIT Margin | 0.16 | 0.26 | 0.22 | 0.16 | - | 0.29 |
| Profit Margin | 0.13 | 0.19 | 0.16 | 0.07 | 0.19 | 0.26 |
| EBITDA | 193.91 Million | 337.27 Million | 324.36 Million | 151.76 Million | - | 381.48 Million |
| Earnings Before Tax Margin | 0.16 | 0.19 | 0.17 | 0.06 | 0.20 | 0.28 |
9534
SIMH3
CAVEN
9885
5227
PSNYW